增强型体外反搏治疗冠心病心绞痛的远期疗效分析
详细信息 查看官网全文
- 论文作者：孟艳玲 ; 高建军
- 年：2016
- 作者机构：邯郸市五矿邯邢矿业职工总医院;
- 论文关键词：冠心病心绞痛 ; 增强型体外反搏 ; 疗效评估
- 英文论文关键词：Coronary heart disease angina pectoris ; Enhanced external counterpulsation ; Efficacy evaluation
- 会议召开时间：2016-11-25
- 会议录名称：湖南中医药大学学报2016/专集：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会论文集
- 语种：中文
- 分类号：R541.4
- 学会代码：HNZY
- 会议名称：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会
- 会议地点：中国广东珠海
- 主办单位：国际数字医学会、Digital Chinese Medicine
- 学会名称：湖南中医药大学期刊杂志社
- 页数：1
- 文件大小：1833k
- 原文格式：D
- 会议级别：全国
摘要
目的探讨采用增强型体外反搏治疗冠心病心绞痛的临床疗效。方法选取2014年3月—2015年8月期间本院收治的冠心病心绞痛患者中选取106例,采用随机数字表法将其分为观察组和对照组,其中对照组患者行常规治疗,观察组在对照组治疗基础上联合增强体外反搏进行治疗,对两组患者的临床治疗效果进行对比分析,并坚持随访1-1.5年,监控患者心血管事件(心源性休克、心肌梗死、心绞痛再入院)的发生率,探讨采用增强型体外反搏治疗后远期效果。结果观察组患者的整体疗效明显优于对照组,差异具有显著性(P<0.05);观察组患者随访期间心绞痛再住院、心肌梗死发生率均明显低于对照组,差异具有显著性(P<0.05)。结论采用增强型体外反搏治疗冠心病心绞痛,可有效促进患者心肌缺血症状的改善,且可以促进侧枝血管形成,改善预后,对于此类患者生存质量的提高具有十分积极的作用。
Objective: To explore the clinical efficacy of enhanced external counterpulsation in the treatment of coronary heart disease and angina pectoris. Methods: 106 patientswith angina pectoris of coronary heart disease admitted to our hospital from March 2014 to August 2015 were randomly divided into observation group and control group. The patients in the controlgroup were treated with routine therapy. The observation group The control group was treated with combined enhanced external counterpulsation. The clinical therapeutic effect of the two groupswas compared and the patients were followed up for 1 to 1.5 years. Cardiac events(cardiogenic shock, myocardial infarction, angina)), And to explore the long-term effect of enhanced externalcounterpulsation.Results: The overall efficacy of the observation group was significantly better than the control group, the difference was significant(P <0.05). The incidence of myocardialinfarction in the observation group was significantly lower than that in the control group(P <0.05).Conclusion: The use of enhanced external counterpulsation in the treatment of angina pectoriscan effectively improve the symptoms of myocardial ischemia, and can promote the formation of collateral vessels, improve the prognosis, for such patients to improve the quality of life has a verypositive role.
Objective: To explore the clinical efficacy of enhanced external counterpulsation in the treatment of coronary heart disease and angina pectoris. Methods: 106 patientswith angina pectoris of coronary heart disease admitted to our hospital from March 2014 to August 2015 were randomly divided into observation group and control group. The patients in the controlgroup were treated with routine therapy. The observation group The control group was treated with combined enhanced external counterpulsation. The clinical therapeutic effect of the two groupswas compared and the patients were followed up for 1 to 1.5 years. Cardiac events(cardiogenic shock, myocardial infarction, angina)), And to explore the long-term effect of enhanced externalcounterpulsation.Results: The overall efficacy of the observation group was significantly better than the control group, the difference was significant(P <0.05). The incidence of myocardialinfarction in the observation group was significantly lower than that in the control group(P <0.05).Conclusion: The use of enhanced external counterpulsation in the treatment of angina pectoriscan effectively improve the symptoms of myocardial ischemia, and can promote the formation of collateral vessels, improve the prognosis, for such patients to improve the quality of life has a verypositive role.
引文
[1]甄子英.运动平板试验评估体外反搏治疗冠心病心绞痛疗效[J].吉林医学.2015(14):3079.
[2]许继艳,常秀武,丁瑞峰,等.中西医结合治疗60例冠心病心绞痛的疗效观察[J].中国生化药物杂志.2014(3):111-113.
[2]许继艳,常秀武,丁瑞峰,等.中西医结合治疗60例冠心病心绞痛的疗效观察[J].中国生化药物杂志.2014(3):111-113.